Interpretation of the 2024 American Heart Association Scientific Statement: evaluation and management of chronic heart failure in children and adolescents with congenital heart disease
10.3760/cma.j.cn101070-20240905-00571
- VernacularTitle:先天性心脏病儿童和青少年慢性心力衰竭的评估和管理：美国心脏协会科学声明解读
- Author:
Yuxing YUAN
1
;
Jinpeng ZHANG
;
Huichao SUN
;
Bo PAN
;
Jie TIAN
Author Information
1. 重庆医科大学附属儿童医院心血管内科，国家儿童健康与疾病临床医学研究中心，儿童发育重大疾病国家国际科技合作基地，重庆市卫生健康委儿童重要器官发育与疾病重点实验室，国家临床重点心血管专科，重庆 400014
- Keywords:
Congenital heart disease;
Heart failure;
Child and adolescent;
Assessment;
Management
- From:
Chinese Journal of Applied Clinical Pediatrics
2024;39(11):824-830
- CountryChina
- Language:Chinese
-
Abstract:
Congenital heart disease (CHD) is one of the leading causes of heart failure (HF) in pediatrics.In 2024, the American Heart Association, based on existing knowledge and research findings, issued its first scientific statement on the assessment and management of HF in children and adolescents with CHD.The statement emphasizes the current lack of understanding of the epidemiology, pathophysiology, staging, and outcomes of chronic HF in pediatrics with CHD, and calls for the development of standardized definitions, monitoring protocols, and treatment strategies to improve the clinical outcomes and quality of life for this population.This article interprets the main content of the statement, aiming to provide reference and guidance for the accurate assessment and comprehensive management of chronic HF in children and adolescents with CHD.
